< Back to latest news & events

Event

HGF webinar: Getting your first filing right

March 2022

Event date: 23rd March 2022

HGF hosted a webinar on Wednesday 23rd March on Getting your first filing right.

One of the most often asked questions of patent attorneys is: “when should we file?” Both timing and content of a first filing should be important strategic decisions. This is especially so in the therapeutic field where wide breadth of claim is desired coupled with maximum use of the available 21 year patent term from first filing. Circumstances can nevertheless necessitate a first filing needing to be considered in a pressurised situation. Even so, strategy from the start needs to be a matter of careful consideration to avoid later problems. The CRISPR patent battle in Europe illustrates well how first filing issues can be a source of costly, unwanted problems which are avoidable.

This presentation covered the considerations required at the first filing stage to align patenting strategy with commercial strategy and minimise problems arising from both formal and content issues. The presentation covered such issues as the evidence required to get over the plausibility hurdle in relation to inventive step and sufficiency as applied to compound and therapeutic use claims, as well as formal considerations such as where to file and who should file, often especially important considerations in the case of collaborative projects involving inventors outside the UK. The presentation also dealt with how to ensure you keep priority of a first filing both legally and to maximise disclosure benefit.

Speaker

Dr Claire Irvine – Partner & Patent Attorney

Watch the webinar:

Latest updates

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

INTA 2025 Annual Meeting Live

The HGF European team will be attending the INTA Annual Meeting Live, which will take place on 17th-21st May in San Diego, US. The conference will connect some of the …

Read article

HGF wins big at the Managing IP EMEA Awards Ceremony 2025

The Annual Managing IP Awards: EMEA Awards 2025 were announced last night, and HGF are proud to have won 7 awards. The Managing IP Awards are highly recognised and respected …

Read article

Plant Patent Infringement in the US Relies on Evidence of Asexual Reproduction

A recent case in the US District Court for the Northern District of Texas (Dallas Division) once again highlights how important the initial pleadings and evidence in patent infringement cases …

Read article

Exam Success at HGF!

HGF is pleased to announce that several of our attorneys have passed their UK Advanced Patent exams! In no specific order, we would like to say well done and a …

Read article

IP Ingredients: How food companies are using IP to stay ahead of the GLP-1 curve

The impact of GLP-1 on the food and beverage sector GLP-1 agonists, best-known under the brand names Ozempic® and Wegovy®, are medicines used to treat type 2 diabetes and obesity. …

Read article

European Innovation Remains Strong: The EPO Patent Index 2024

The Patent Index 2024, recently published by the European Patent Office (EPO), provides a rich dataset from which key patent trends can be identified. The data shows that demand for …

Read article